vs

Side-by-side financial comparison of Bloom Energy Corp (BE) and Enovis CORP (ENOV). Click either name above to swap in a different company.

Bloom Energy Corp is the larger business by last-quarter revenue ($751.1M vs $548.9M, roughly 1.4× Enovis CORP). Bloom Energy Corp runs the higher net margin — 9.4% vs -104.1%, a 113.5% gap on every dollar of revenue. On growth, Enovis CORP posted the faster year-over-year revenue change (-2.2% vs -3.4%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs 9.8%).

KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

BE vs ENOV — Head-to-Head

Bigger by revenue
BE
BE
1.4× larger
BE
$751.1M
$548.9M
ENOV
Growing faster (revenue YoY)
ENOV
ENOV
+1.3% gap
ENOV
-2.2%
-3.4%
BE
Higher net margin
BE
BE
113.5% more per $
BE
9.4%
-104.1%
ENOV
Faster 2-yr revenue CAGR
BE
BE
Annualised
BE
51.7%
9.8%
ENOV

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BE
BE
ENOV
ENOV
Revenue
$751.1M
$548.9M
Net Profit
$70.7M
$-571.1M
Gross Margin
30.0%
59.9%
Operating Margin
17.3%
-101.7%
Net Margin
9.4%
-104.1%
Revenue YoY
-3.4%
-2.2%
Net Profit YoY
396.7%
18.8%
EPS (diluted)
$0.44
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BE
BE
ENOV
ENOV
Q1 26
$751.1M
Q4 25
$772.8M
$548.9M
Q3 25
$513.3M
$564.5M
Q2 25
$396.3M
$558.8M
Q1 25
$319.3M
Q4 24
$567.0M
$561.0M
Q3 24
$321.8M
$505.2M
Q2 24
$326.5M
$525.2M
Net Profit
BE
BE
ENOV
ENOV
Q1 26
$70.7M
Q4 25
$1.4M
$-571.1M
Q3 25
$-23.0M
$-36.7M
Q2 25
$-42.2M
$-56.0M
Q1 25
$-23.4M
Q4 24
$105.2M
$-703.2M
Q3 24
$-14.6M
$-31.5M
Q2 24
$-61.2M
$-18.6M
Gross Margin
BE
BE
ENOV
ENOV
Q1 26
30.0%
Q4 25
31.0%
59.9%
Q3 25
29.5%
59.3%
Q2 25
27.0%
59.5%
Q1 25
27.8%
Q4 24
38.7%
54.8%
Q3 24
24.5%
56.7%
Q2 24
21.0%
55.0%
Operating Margin
BE
BE
ENOV
ENOV
Q1 26
17.3%
Q4 25
11.3%
-101.7%
Q3 25
1.5%
-3.0%
Q2 25
-0.9%
-8.4%
Q1 25
-6.0%
Q4 24
18.5%
-118.5%
Q3 24
-3.0%
-6.3%
Q2 24
-7.1%
-8.4%
Net Margin
BE
BE
ENOV
ENOV
Q1 26
9.4%
Q4 25
0.2%
-104.1%
Q3 25
-4.5%
-6.5%
Q2 25
-10.6%
-10.0%
Q1 25
-7.3%
Q4 24
18.5%
-125.4%
Q3 24
-4.5%
-6.2%
Q2 24
-18.7%
-3.5%
EPS (diluted)
BE
BE
ENOV
ENOV
Q1 26
$0.44
Q4 25
$99.91
$-9.99
Q3 25
$-100.00
$-0.64
Q2 25
$-0.18
$-0.98
Q1 25
$-0.10
Q4 24
$0.45
$-12.69
Q3 24
$-0.06
$-0.58
Q2 24
$-0.27
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BE
BE
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$33.6M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$948.0K
$2.0B
Total Assets
$4.7B
$4.4B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BE
BE
ENOV
ENOV
Q1 26
Q4 25
$2.5B
$33.6M
Q3 25
$595.1M
$44.1M
Q2 25
$574.8M
$38.5M
Q1 25
$794.8M
Q4 24
$802.9M
$48.2M
Q3 24
$495.7M
$35.4M
Q2 24
$581.7M
$35.0M
Total Debt
BE
BE
ENOV
ENOV
Q1 26
Q4 25
$2.6B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$1.1B
$1.4B
Q1 25
$1.1B
Q4 24
$1.1B
$1.3B
Q3 24
$1.1B
$1.3B
Q2 24
$1.1B
$1.3B
Stockholders' Equity
BE
BE
ENOV
ENOV
Q1 26
$948.0K
Q4 25
$768.6M
$2.0B
Q3 25
$653.1M
$2.6B
Q2 25
$594.6M
$2.6B
Q1 25
$578.3M
Q4 24
$562.5M
$2.6B
Q3 24
$430.9M
$3.3B
Q2 24
$423.3M
$3.3B
Total Assets
BE
BE
ENOV
ENOV
Q1 26
$4.7B
Q4 25
$4.4B
$4.4B
Q3 25
$2.6B
$5.0B
Q2 25
$2.5B
$4.9B
Q1 25
$2.6B
Q4 24
$2.7B
$4.7B
Q3 24
$2.6B
$5.6B
Q2 24
$2.5B
$5.4B
Debt / Equity
BE
BE
ENOV
ENOV
Q1 26
Q4 25
3.41×
0.67×
Q3 25
1.73×
0.54×
Q2 25
1.91×
0.53×
Q1 25
1.96×
Q4 24
2.01×
0.52×
Q3 24
2.62×
0.40×
Q2 24
2.66×
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BE
BE
ENOV
ENOV
Operating Cash FlowLast quarter
$82.6M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BE
BE
ENOV
ENOV
Q1 26
Q4 25
$418.1M
$82.6M
Q3 25
$19.7M
$47.8M
Q2 25
$-213.1M
$-1.6M
Q1 25
$-110.7M
Q4 24
$484.2M
$88.3M
Q3 24
$-69.5M
$53.6M
Q2 24
$-175.5M
$7.8M
Free Cash Flow
BE
BE
ENOV
ENOV
Q1 26
Q4 25
$395.1M
$29.1M
Q3 25
$7.4M
$3.4M
Q2 25
$-220.4M
$-44.9M
Q1 25
$-124.9M
Q4 24
$473.1M
$35.1M
Q3 24
$-83.8M
$2.4M
Q2 24
$-187.5M
$-31.6M
FCF Margin
BE
BE
ENOV
ENOV
Q1 26
Q4 25
51.1%
5.3%
Q3 25
1.4%
0.6%
Q2 25
-55.6%
-8.0%
Q1 25
-39.1%
Q4 24
83.4%
6.3%
Q3 24
-26.0%
0.5%
Q2 24
-57.4%
-6.0%
Capex Intensity
BE
BE
ENOV
ENOV
Q1 26
Q4 25
3.0%
9.7%
Q3 25
2.4%
7.9%
Q2 25
1.8%
7.7%
Q1 25
4.5%
Q4 24
2.0%
9.5%
Q3 24
4.4%
10.1%
Q2 24
3.7%
7.5%
Cash Conversion
BE
BE
ENOV
ENOV
Q1 26
Q4 25
293.18×
Q3 25
Q2 25
Q1 25
Q4 24
4.60×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BE
BE

Product$653.3M87%
Service$61.9M8%
Installation$25.9M3%
Electricity$9.9M1%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons